Price Target Changes｜Keybanc cut Workday to $312; Keybanc cut Coupa Software to $175

Benzinga2022-03-01
  • Keybanc cut the price target on Workday, Inc. from $345 to $312. Workday shares rose 5.7% to $242.00 in pre-market trading.
  • SVB Leerink lowered Veracyte, Inc. price target from $45 to $40. Veracyte shares gained 3.2% to close at $27.80 on Monday.
  • Goldman Sachs cut the price target on Foot Locker, Inc. from $63 to $35. Foot Locker shares fell 3.1% to $30.65 in pre-market trading.
  • Piper Sandler lowered the price target for ON24, Inc. from $25 to $17. ON24 shares fell 4.6% to $14.89 in pre-market trading.
  • Keybanc lowered Ambarella, Inc. price target from $230 to $160. Ambarella shares dipped 20% to $111.77 in pre-market trading.
  • Credit Suisse cut the price target on GoodRx Holdings, Inc. from $41 to $27. GoodRx shares fell 34.1% to $18.07 in pre-market trading.
  • Jefferies reduced the price target for Gemini Therapeutics, Inc. from $23 to $1.5. Gemini Therapeutics shares fell 4.9% to close at $1.36 on Monday.
  • Keybanc cut Coupa Software Incorporated price target from $200 to $175. Coupa Software shares rose 3.2% to $124.90 in pre-market trading.
  • B. Riley Securities raised Quanta Services, Inc. price target from $122 to $129. Quanta Services shares fell 1.8% to $107.00 in pre-market trading.
  • Societe Generale cut Farfetch Limited price target from $26 to $23. Farfetch shares rose 0.5% to $19.15 in pre-market trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
10